Karine Tawagi MD· @DrKarineTawagi · X·· 2 天前评分90
正文 · 原文
Full house for Bladder/RCC updates first with #KN866 #ESMO26
Gem/cis in MIBC + placebo or pembro
(➖) study & less relevance in the era of EVP SOC
Vs similar trial NIAGARA was ➕
pCR 44.4% vs 35.8%
EFS & OS not significant
We wait #VOLGA tomorrow for more in this space
1463 浏览 · 15 赞 · 3 转发 · 0 回复
会议摘要
LBA2按 Presidential Symposium I 对上
Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial
https://esmocongress.esmo.orgVOLGA
https://esmocongress.esmo.org来源：Karine Tawagi MD · x.com